Lauren Kerrigan
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial.
Journal: American journal of respiratory and critical care medicine
Published: March 05, 2026
Deep phenotyping of a modified diabetic cardiomyopathy mouse model which reflects clinical disease progression.
Journal: Diabetology & metabolic syndrome
Published: June 17, 2025
Proteome Alterations in Cardiac Fibroblasts: Insights from Experimental Myocardial Infarction and Clinical Ischaemic Cardiomyopathy.
Journal: International journal of molecular sciences
Published: March 04, 2025
Sacubitril/Valsartan attenuates progression of diabetic cardiomyopathy through immunomodulation properties: an opportunity to prevent progressive disease.
Journal: Cardiovascular diabetology
Published: December 18, 2024
Integrin beta-like 1 is regulated by DNA methylation and increased in heart failure patients.
Journal: ESC heart failure
Published: April 22, 2024
Pre-Eclampsia Biomarkers for Women With Type 1 Diabetes Mellitus: A Comprehensive Review of Recent Literature.
Journal: Frontiers in bioengineering and biotechnology
Published: November 05, 2021
Targeting of cathepsin S reduces cystic fibrosis-like lung disease.
Journal: The European respiratory journal
Published: August 10, 2018
Inflammation and host-pathogen interaction: Cause and consequence in cystic fibrosis lung disease.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 21, 2017
Cystic fibrosis epithelial cells are primed for apoptosis as a result of increased Fas (CD95).
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 07, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026